Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Bortezomib (Velcade, PS-341) in Combination With Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults With Refractory/Recurrent Hodgkin Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00381940
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:15.038474+00:00
Published At
2014-04-10T00:00:00+00:00
Record Updated At
2021-03-24
Results Posted At
2014-04-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Lymphocyte Depletion Hodgkin Lymphoma", "Adult Lymphocyte Predominant Hodgkin Lymphoma", "Adult Mixed Cellularity Hodgkin Lymphoma", "Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma", "Adult Nodular Sclerosis Hodgkin Lymphoma", "Childhood Lymphocyte Depletion Hodgkin Lymphoma", "Childhood Lymphocyte Predominant Hodgkin Lymphoma", "Childhood Mixed Cellularity Hodgkin Lymphoma", "Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma", "Childhood Nodular Sclerosis Hodgkin Lymphoma", "Recurrent Adult Hodgkin Lymphoma", "Recurrent/Refractory Childhood Hodgkin Lymphoma", "Stage I Adult Hodgkin Lymphoma", "Stage I Childhood Hodgkin Lymphoma", "Stage II Adult Hodgkin Lymphoma", "Stage II Childhood Hodgkin Lymphoma", "Stage III Adult Hodgkin Lymphoma", "Stage III Childhood Hodgkin Lymphoma", "Stage IV Adult Hodgkin Lymphoma", "Stage IV Childhood Hodgkin Lymphoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-03-24"
protocolSection.identificationModule.nctId
"NCT00381940"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Bortezomib (Velcade, PS-341) in Combination With Ifosfamide/Vinorelbine in Pediatric Patients and Young Adults With Refractory/Recurrent Hodgkin Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2014-04-10"

Study condition terms

  • Adult Lymphocyte Depletion Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Adult Lymphocyte Predominant Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Adult Mixed Cellularity Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Adult Nodular Sclerosis Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Lymphocyte Depletion Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Lymphocyte Predominant Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Mixed Cellularity Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Childhood Nodular Sclerosis Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Recurrent/Refractory Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage I Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage II Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage III Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)
  • Stage IV Childhood Hodgkin Lymphoma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.